| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
26,320,000 |
| Market
Cap: |
3.83(M) |
| Last
Volume: |
169,426 |
Avg
Vol: |
168,953 |
| 52
Week Range: |
$0.1454 - $0.1454 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Scott John K Jr. |
|
– • • |
2023-11-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,270) |
0 |
|
- |
|
| Stefanelli Jill |
|
– • – |
2023-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
691,667 |
941,667 |
|
- |
|
| Moss Dana J |
|
– • – |
2023-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
616,667 |
866,667 |
|
- |
|
| Dais Craig |
CHIEF FINANCIAL OFFICER |
• – – |
2023-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
973,633 |
973,633 |
|
- |
|
| Moss Dana J |
|
– • – |
2023-07-11 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
250,000 |
|
- |
|
| Scott John K Jr. |
Director |
• • • |
2023-06-29 |
4 |
A |
$0.09 |
$1,073,600 |
D/D |
12,200,000 |
31,755,832 |
|
- |
|
| Stefanelli Jill |
|
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
250,000 |
|
- |
|
| Scott John K Jr. |
Director |
• • • |
2023-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,508,672 |
19,555,832 |
|
- |
|
| Scott John K Jr. |
Director |
• • • |
2023-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(990) |
2,270 |
|
- |
|
| Cappello Alexander L |
Director |
• • – |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
67,727 |
|
- |
|
| Witter Malcolm G |
Director |
• • – |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
163,888 |
|
- |
|
| Scott John K Jr. |
Director |
• • • |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
8,109,645 |
|
- |
|
| Bhalla Amit |
Director |
• • – |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
71,818 |
|
- |
|
| Witter Malcolm G |
Director |
• • – |
2022-11-30 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,250 |
165,138 |
|
- |
|
| Wilson Josh M |
Director |
• • – |
2022-11-29 |
4 |
A |
$0.00 |
$30 |
D/D |
30,000 |
30,000 |
|
- |
|
| Bhalla Amit |
Director |
• • – |
2022-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
70,568 |
|
- |
|
| Witter Malcolm G |
Director |
• • – |
2022-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
163,888 |
|
- |
|
| Scott John K Jr. |
Director |
• • • |
2022-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
8,108,395 |
|
- |
|
| Cappello Alexander L |
Director |
• • – |
2022-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
66,477 |
|
- |
|
| Witter Malcolm G |
Director |
• • – |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
161,388 |
|
- |
|
| Scott John K Jr. |
Director |
• • • |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
8,105,895 |
|
- |
|
| Bhalla Amit |
Director |
• • – |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
68,068 |
|
- |
|
| Cappello Alexander L |
Director |
• • – |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
63,977 |
|
- |
|
| Rosol Michael Stanley |
Chief Medical Officer |
• • – |
2022-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
41,150 |
55,725 |
|
- |
|
| Witter Malcolm G |
Director |
• • – |
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
158,888 |
|
- |
|
192 Records found
|
|
Page 1 of 8 |
|
|
